わかもと製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4512/E00928 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/11/08 | 日証協 | 307,145株 | +0.62% | 30,100株 | -77.05% | 409,733株 | +0.34% | 1,500株 | -83.87% |
2019/11/01 | 日証協 | 305,245株 | +7.7% | 131,136株 | +836.69% | 408,333株 | -2.67% | 9,300株 | +389.47% |
2019/10/25 | 日証協 | 283,409株 | -1.49% | 14,000株 | -86.1% | 419,533株 | +0.1% | 1,900株 | -63.46% |
2019/10/18 | 日証協 | 287,709株 | -1.91% | 100,700株 | -7.95% | 419,133株 | -1.11% | 5,200株 | -66.88% |
2019/10/11 | 日証協 | 293,309株 | -0.81% | 109,400株 | -62.8% | 423,833株 | +1.63% | 15,700株 | -32.07% |
2019/10/04 | 日証協 | 295,709株 | -1.76% | 294,100株 | +154.41% | 417,033株 | +0.05% | 23,111株 | +579.54% |
2019/09/27 | 日証協 | 301,000株 | -1.05% | 115,600株 | -9.78% | 416,813株 | -4.49% | 3,401株 | -75.53% |
2019/09/20 | 日証協 | 304,200株 | +0.86% | 128,138株 | +6.31% | 436,424株 | -9.12% | 13,900株 | +69.51% |
2019/09/13 | 日証協 | 301,600株 | -0.76% | 120,531株 | -46.45% | 480,224株 | -0.15% | 8,200株 | -26.79% |
2019/09/06 | 日証協 | 303,909株 | -0.33% | 225,100株 | -7.87% | 480,933株 | -0.85% | 11,200株 | -57.25% |
2019/08/30 | 日証協 | 304,921株 | -1.2% | 244,324株 | -20.67% | 485,033株 | +2.3% | 26,200株 | +29.7% |
2019/08/23 | 日証協 | 308,609株 | -1.53% | 308,000株 | +41.54% | 474,133株 | +1.93% | 20,200株 | +53.03% |
2019/08/16 | 日証協 | 313,409株 | -1.69% | 217,600株 | +409.6% | 465,133株 | +1.79% | 13,200株 | -50% |
2019/08/09 | 日証協 | 318,809株 | +6.52% | 42,700株 | -82.21% | 456,933株 | +2.91% | 26,400株 | +214.29% |
2019/08/02 | 日証協 | 299,309株 | +1.66% | 240,000株 | +329.34% | 444,033株 | +0.57% | 8,400株 | -26.32% |
2019/07/26 | 日証協 | 294,409株 | -2.26% | 55,900株 | -73.9% | 441,533株 | -2.5% | 11,400株 | -27.39% |
2019/07/19 | 日証協 | 301,209株 | +6.13% | 214,200株 | +387.93% | 452,833株 | +4.07% | 15,700株 | -52.57% |
2019/07/12 | 日証協 | 283,809株 | +2.64% | 43,900株 | -86.74% | 435,133株 | +4.32% | 33,100株 | -0.9% |
2019/07/05 | 日証協 | 276,509株 | +1.58% | 331,000株 | +410.02% | 417,133株 | -2.09% | 33,400株 | -58.2% |
※株式分割は考慮していませんのでご注意ください。
Page Top